AzTrials
AzTrials

StrokeNCT05183672

Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic

A study testing Telecare consultation and Usual face-to-face consultation in people with Stroke, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Since 2017, Hong Kong has provided post-acute stroke services in clinics operated by stroke advanced practice nurses (APNs). Currently, the applicability of the clinics has been further limited by the emergence of the coronavirus (COVID-19) pandemic due to restrictions on visits to the clinics and tightened social… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
Telecare consultation and Usual face-to-face consultation
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
196 participants
Where
1 siteHong Kong
Study dates
1 Dec 2022to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • confirmed diagnosis of stroke within 1 month before enrolment, will be discharged home within a week, aged 18 or above, cognitively competent with a score equal to or greater than 22 in the Montreal Cognitive Assessment Hong Kong version, own a smartphone

Who cannot join

  • have unaccompanied hearing or vision loss, cannot be reached by phone, bedbound, have no Internet connection at home, participating in other clinical trials at the same time, require physical contact, i.e. wound dressing

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Queen Elizabeth Hospital

    Kowloon

Other trials in Hong Kong

About this study

Official title: Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic During COVID-19 and Beyond: A Hybrid Type 2 Implementation-effectiveness Randomized Trial

Since 2017, Hong Kong has provided post-acute stroke services in clinics operated by stroke advanced practice nurses (APNs). Currently, the applicability of the clinics has been further limited by the emergence of the coronavirus (COVID-19) pandemic due to restrictions on visits to the clinics and tightened social distancing requirements. Telecare consultations may be a viable option for contributing more flexible, interactive, and cost-efficient care models to support stroke survivors over the longer run. The present study takes advantage of this opportunity by utilizing implementation science to simultaneously implement and evaluate a telecare model of care in a nurse-led post-acute stroke clinic.

Conditions
Stroke
Being tested
Telecare consultation, Usual face-to-face consultation
Keywords
stroke, telecare consultation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telecare consultationProcedure or surgery

    Using Zoom to communicate with patients

  • Usual face-to-face consultationProcedure or surgery

    Face-to-face communication with patients

Study groups in NCT05183672
Study groupRoleWhat they receive
Intervention groupExperimentalParticipants will receive three tertiary stroke care consultations provided by stroke nurses via telecare in 3 months.
Receives: Procedure: Telecare consultation
Control groupPlacebo comparatorParticipants will receive three usual face-to-face consultations provided by stroke nurses in 3 months
Receives: Procedure: Usual face-to-face consultation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chang in Degree of disability after stroke

    Simplified modified Rankin scale will be used to measure the degree of disability for stroke patients. The scale has three questions to identify whether the patient has a score from 0 to 5, with higher scores representing higher degree of disability.

    Measured: baseline, three months when the program is completed, three months after the program is completed.

Secondary outcomes (6)
  1. Incidence of the recurrence of stroke

    The percentage of participants who re-admitted to hospital because of recurrent stroke

    Measured: baseline, three months when the program is completed, three months after the program is completed.

  2. Change of Quality of life, which measures an individual perception oftheir position in life. It includes physical and mental health.

    Quality of life will be measured using the Hong Kong version of EuroQol 5-dimension. The scale has five subdomains, which include mobility, self-care, usual activities, pain and discomfort, and anxiety and depression. Since the scale has 5 items, each digit in the five digit codes refers to the status of each dimension, ranging from 1 for no problem, to 5 for sever problem. A higher scores indicate better quality of life.

    Measured: baseline, three months when the program is completed, three months after the program is completed.

  3. Change of Post-stroke depression

    Post-stroke depression will be measured using the Chinese version of the Geriatric Depression scale. This scale has a minimum score of 0 and a maximum score of 15. Lower scores represent lower depression level.

    Measured: baseline, three months when the program is completed, three months after the program is completed.

  4. Change of Medication adherence

    Medication adherence will be determined using the Adherence to Refills and Medications Scale. The scale produces an overall adherence score of 10-40, with lower scores indicating better adherence.

    Measured: baseline, three months when the program is completed, three months after the program is completed.

  5. Change of Social participation

    Social participation will be measured using the 11-item Reintegration to Normal Living index. This scale is used to measure whether the patient has participated in several social activities before and after occurrence of stroke. The scale yields total score from 0-22, with higher scores indicating poorer social participation.

    Measured: baseline, three months when the program is completed, three months after the program is completed.

  6. Number of attendances at a general practitioners' office, emergency department, hospital, and general out-patient clinic

    To measure the utilization of healthcare services by stroke patient before and after the intervention

    Measured: baseline, three months when the program is completed, three months after the program is completed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2022
  2. Study start1 Dec 2022
  3. Primary completion30 Oct 2025
  4. Study completion30 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
196 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05183672
Sponsor's protocol ID
A0036516
Status last verified
Sep 2026
First submitted
7 Dec 2021
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wong AKC, Kwok VWY, Wong FKY, Tong DWK, Yuen BMK, Fong CS, Chan ST, Li WC, Zhou S, Lee AYL. Improving post-acute stroke follow-up care by adopting telecare consultations in a nurse-led clinic: Study protocol of a hybrid implementation-effectiveness trial. J Adv Nurs. 2024 Mar;80(3):1222-1231. doi: 10.1111/jan.15960. Epub 2023 Nov 10.

    PubMed 37950400

Questions about this trial

What is this clinical trial studying?

A study testing Telecare consultation and Usual face-to-face consultation in people with Stroke, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chang in Degree of disability after stroke (time frame: baseline, three months when the program is completed, three months after the program is completed.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05183672, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in